Stocktoria
Oruka Therapeutics, Inc. ORKA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-07-21
Oruka Therapeutics, Inc. statistics & valuation
Market cap$5.5B
P / B11.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Return on assets | -21.6% | -14.1% | -23.0% | -35.2% | -19.3% |
| Return on equity | -22.3% | -14.4% | -23.8% | -37.9% | -20.9% |
| Current ratio | 22.37 | 59.01 | 37.72 | 15.56 | 14.28 |
Source: SEC EDGAR filings · CIK 0000907654 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.